Mohamed Moustafa Ibrahim

Also affiliated with University of Tennessee Health Science Center

MedicinePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “In Silico Screening and In Vivo Evaluation of Potential CACNA2D1 Antagonists as Intraocular Pressure-Reducing Agents in Glaucoma Therapy”.

In Silico Screening and In Vivo Evaluation of Potential CACNA2D1 Antagonists as Intraocular Pressure-Reducing Agents in Glaucoma Therapy

Pharmaceuticals(2021)10.3390/ph14090887

N/A

0DataRank · unranked

10 citations

Mohamed Moustafa Ibrahim, Hao Chen, Wěi Li, Monica M. Jablonski, Hanxuan Li

Nimodipine Nanoparticles: A Promising Approach for Glaucoma Management

Pharmaceutics(2025)10.3390/pharmaceutics17111363

N/A

0DataRank · unranked

2 citations

Sara N. Maria, Monica M. Jablonski, Mohamed Moustafa Ibrahim, Doaa Nabih Maria